Zhong Chen
Fuzhou Second Hospital(CN)
Publications by Year
Research Areas
NF-κB Signaling Pathways, Cancer-related molecular mechanisms research, RNA regulation and disease, RNA modifications and cancer, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin(2014)1,553 cited
- Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.(1999)
- Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.(2001)
- Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.(1999)
- → Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma lines(2002)231 cited
- → Constitutive activation of transcription factors NF-?B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines(1999)222 cited
- → Emergence of protein kinase CK2 as a key target in cancer therapy(2010)193 cited
- Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.(2001)
- → EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy(2010)177 cited
- → Nuclear Factor-κB is an Important Modulator of the Altered Gene Expression Profile and Malignant Phenotype in Squamous Cell Carcinoma(2004)167 cited